个人科研网厅 | | 帮助
高级检索
当前位置： 首页 > 详情页

On-Site Diagnostic Ability of CEUS/CT/MRI for Hepatocellular Carcinoma (2019-2022): A Multicenter Study

| 导出 | |

文献详情

资源类型：
WOS体系：
Pubmed体系：

收录情况： ◇ SCIE

作者：
Yang Qi[1,2] * ; Zheng Rongqin[3] ; Zhou Jianhua[4] ; Tang Lina[5] ; Zhang Ruifang[6] ; Jiang Tianan[7] ; Jing Xiang[8] ; Liao Jintang[9] ; Cheng Wen[10] ; Zhao Cheng[11] ; Liu Cun[12] ; Dietrich Chirstoph F[13] ; Cui Xinwu[14] ; Cai Wenjia[1] ; Wu JiaPeng[1] ; Yu Fei[2] ; Cheng Zhigang[1] ; Liu Fangyi[1] ; Han Zhiyu[1] ; Yu Xiaoling[1] ; Yu Jie[1,*1] ; Liang Ping[1,*1] ;
单位： [1]Department of Interventional Ultrasound, Chinese PLA General Hospital, Beijing, China [2]Department of Medical Ultrasound, Peking University Shenzhen Hospital, Shenzhen, China [3]Department of Ultrasound, Guangdong Key Laboratory of Liver Disease Research, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China [4]Department of Ultrasound, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China [5]Department of Diagnostic Ultrasound, Fujian Cancer Hospital & Fujian Medical University Cancer Hospital, Fuzhou, China [6]Department of Ultrasound, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China [7]Department of Ultrasound Medicine, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China [8]Department of Ultrasound, Tianjin Third Central Hospital, Tianjin, China [9]Department of Diagnostic Ultrasound, Xiangya Hospital Central South University, Changsha, China [10]Department of Ultrasound, Harbin Medical University Cancer Hospital, Harbin, China [11]Department of Ultrasound, The Affiliated Hospital of Qingdao University, Qingdao, China [12]Department of Ultrasound, Jinan Central Hospital Affiliated to Shandong First Medical University, Jinan, China [13]Department Allgemeine Innere Medizin (DAIM), Kliniken Hirslanden Beau Site, Bern, Switzerland [14]Department of Medical Ultrasound, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
出处：
DOI： 10.1002/jum.16321
ISSN：

摘要：
To compare the on-site diagnostic performance of contrast-enhanced ultrasound (CEUS), computed tomography (CECT), and magnetic resonance imaging (CEMRI) for hepatocellular carcinoma (HCC) across diverse practice settings.Between May 2019 and April 2022, a total of 2085 patients with 2320 pathologically confirmed focal liver lesions (FLLs) were enrolled. Imaging reports were compared with results from pathology analysis. Diagnostic performance was analyzed in defined size, high-risk factors for HCC, and hospital volume categories.Three images achieved similar diagnostic performance in classifying HCC from 16 types of FLLs, including HCC ≤2.0 cm. For HCC diagnosis at low-volume hospitals and HCC with high-risk factors, the accuracy and specificity of CEUS were comparable to CECT and CEMRI, while the sensitivity of CEUS (77.4 and 89.5%, respectively) was inferior to CEMRI (87.0 and 92.8%, respectively). The diagnostic accuracy of CEUS + CEMRI and CEUS + CECT increased by 7.8 and 6.2% for HCC ≤2.0 cm, 8.0 and 5.0% for HCC with high-risk factors, and 7.4 and 5.5% for HCC at low-volume hospitals, respectively, compared with CEMRI/CECT alone.Compared with CECT and CEMRI, CEUS provides adequate diagnostic performance in clinical first-line applications at high-volume hospitals. Moreover, a higher diagnostic performance for HCC is achieved by combining CEUS with CECT/CEMRI compared with any single imaging technique.© 2023 American Institute of Ultrasound in Medicine.

基金：
This work was supported by Grants 82102076, 81971625, and 91859201 from the National Scientific Foundation Committee of China, Grant JQ18021 from the National Scientific Foundation Committee of Beijing, Military Fund for Geriatric Diseases (20BJZ42), the National Clinical Research Center for Geriatric Diseases (NCRCG-PLAGH-2019011) of Chinese PLA General Hospital, and the Scientific Research Foundation of Peking University Shenzhen Hospital (No. KYQD2021099). The data of the present study belonged to our registered study in Clinical-Trials.gov and the identifier number is NCT03871140.
语种：
外文
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2022]版：
大类 | 4 区 医学
小类 | 3 区 声学 4 区 核医学
最新[2025]版：
大类 | 3 区 医学
小类 | 3 区 声学 3 区 核医学
JCR分区：
出版当年[2021]版：
Q2 ACOUSTICS Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
最新[2023]版：
Q2 ACOUSTICS Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

影响因子： 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者：
第一作者单位： [1]Department of Interventional Ultrasound, Chinese PLA General Hospital, Beijing, China [2]Department of Medical Ultrasound, Peking University Shenzhen Hospital, Shenzhen, China
通讯作者：
通讯机构： [1]Department of Interventional Ultrasound, Chinese PLA General Hospital, Beijing, China [*1]Department of Interventional Ultrasound, Chinese PLA General Hospital, 28 Fuxing Road, Beijing 100853, China.
推荐引用方式(GB/T 7714)：
Yang Qi,Zheng Rongqin,Zhou Jianhua,et al.On-Site Diagnostic Ability of CEUS/CT/MRI for Hepatocellular Carcinoma (2019-2022): A Multicenter Study[J].JOURNAL OF ULTRASOUND IN MEDICINE.2023,42(12):2825-2838.doi:10.1002/jum.16321.
APA：
Yang Qi,Zheng Rongqin,Zhou Jianhua,Tang Lina,Zhang Ruifang...&Liang Ping.(2023).On-Site Diagnostic Ability of CEUS/CT/MRI for Hepatocellular Carcinoma (2019-2022): A Multicenter Study.JOURNAL OF ULTRASOUND IN MEDICINE,42,(12)
MLA：
Yang Qi,et al."On-Site Diagnostic Ability of CEUS/CT/MRI for Hepatocellular Carcinoma (2019-2022): A Multicenter Study".JOURNAL OF ULTRASOUND IN MEDICINE 42..12(2023):2825-2838

资源点击量：426 今日访问量：2 总访问量：410 更新日期：2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有：重庆聚合科技有限公司 渝ICP备12007440号-3 地址：重庆市两江新区泰山大道西段8号坤恩国际商务中心16层（401121）